
Real-World Efficacy & Safety of NMOSD Treatments
A recent study, “Real‑World Efficacy and Safety of Neuromyelitis Optica Spectrum Disorder Disease‑Modifying Treatments,” showed that in routine practice, approved NMOSD therapies reduce relapse rates and offer better safety than older treatments, reinforcing their value for patients. (Read the article here: https://pubmed.ncbi.nlm.nih.gov/41494145/) To mark NMO Awareness Month 2026, we’ll be joined by Dr. Shamik Bhattacharyya, […]




